IR
INSIDER · JAZZ · Jazz Pharmaceuticals plc · EVP, GLOBAL HEAD OF R&D & CMO
Iannone Robert
Every open-market transaction filed under this name, Aug 27 to Aug 27.
Filings
6
0 buys · 6 sells
Bought
—
open market, at cost
Sold
$19.2M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Aug 27 | JAZZ | Jazz Pharmaceuticals plc | EVP, Global Head of R&D & CMO | Sell | 300 | $252.76 | $76K | −16.8% |
| Aug 27 | JAZZ | Jazz Pharmaceuticals plc | EVP, Global Head of R&D & CMO | Sell | 9,259 | $251.95 | $2.3M | −16.5% |
| Aug 27 | JAZZ | Jazz Pharmaceuticals plc | EVP, Global Head of R&D & CMO | Sell | 19,639 | $250.60 | $4.9M | −16.0% |
| Aug 27 | JAZZ | Jazz Pharmaceuticals plc | EVP, Global Head of R&D & CMO | Sell | 18,113 | $250.02 | $4.5M | −15.8% |
| Aug 27 | JAZZ | Jazz Pharmaceuticals plc | EVP, Global Head of R&D & CMO | Sell | 11,423 | $248.67 | $2.8M | −15.4% |
| Aug 27 | JAZZ | Jazz Pharmaceuticals plc | EVP, Global Head of R&D & CMO | Sell | 18,187 | $247.86 | $4.5M | −15.1% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.